Alterations to brain homeostasis during development are reflected in the neurochemical profile determined noninvasively by 1 H magnetic resonance spectroscopy. We determined longitudinal biochemical modifications in the cortex, hippocampus, and striatum of C57BL/6 mice aged between 3 and 24 months . The regional neurochemical profile evolution indicated that aging induces general modifications of neurotransmission processes (reduced GABA and glutamate), primary energy metabolism (altered glucose, alanine, and lactate) and turnover of lipid membranes (modification of choline-containing compounds and phosphorylethanolamine), which are all probably involved in the frequently observed age-related cognitive decline. Interestingly, the neurochemical profile was different in male and female mice, particularly in the levels of taurine that may be under the control of estrogen receptors. These neurochemical profiles constitute the basal concentrations in cortex, hippocampus, and striatum of healthy aging male and female mice.
Introduction
Aging is accompanied by various cellular challenges in the brain, which lead to homeostatic alterations and ultimately result in the reduction of neuronal function and cognitive performance (Bizon et al., 2012) . Although aging mechanisms are not fully understood, age-dependent brain modifications are likely reflected in alterations of the regional distribution of levels of neurochemicals. The concentration patterns of these compounds composing the neurochemical profile vary with cellular composition and function of the tissue, thus reflecting the structural differentiation of cerebral networks in a region-specific manner, and are affected by modification of functional states and by neuropathologies (reviewed in . This supports the use of the neurochemical profile as region-and time-specific biomarker and, indeed, its noninvasive detection by magnetic resonance spectroscopy (MRS) has emerged as an important research tool in translational neuroscience. Neurochemical profiling has thus been successfully used to reliably probe brain biochemical modifications upon disease and/or treatment monitoring in mice (Berthet et al., 2011; Zacharoff et al. 2012) , rats Rao et al., 2011) , or humans (Bustillo et al., 2009; Seaquist et al., 2005) . Each neuropathology has different etiology, is region specific and occurs with most prominence at a particular age range. For example, while schizophrenia is a neurodevelopment disorder, other nowadays-common disorders like Alzheimer's disease or Parkinson's disease mostly affect the middle aged and rapidly increasing elderly population. In humans, studies in elderly subjects were performed at low-magnetic field and focused on the most prominent resonances in 1 H nuclear magnetic resonance (NMR) spectra rather than determining an extensive neurochemical profile (Chang et al., 1996; Gruber et al., 2008; Schuff et al., 1999 Schuff et al., , 2001 . In experimental animal models, the extended neurochemical profile detected in vivo by high-field 1 H MRS has been studied from birth to adulthood, disregarding the aging brain. Contributing for this is the fact that genetic manipulations in rodents allow to reach disease phenotypes at early age. Therefore, age-dependent modifications to the neurochemical profile remain to be investigated.
Most magnetic resonance scanners available for clinical routine are operating at low-magnetic field. Therefore, the extensive neurochemical profile observed in animal studies is not directly applicable to the clinical environment. Nevertheless, even at 1.5 T, several metabolites are distinguishable in 1 H MRS at short echo time (discussed in . Then, analysis with appropriate algorithms provides measurements of several compounds such as creatine, N-acetylaspartate (NAA), myo-inositol, choline-containing compounds, and glutamate plus glutamine (the so called "Glx"). In a clinical 3.0 T system, Mekle et al. (2009) achieved spectral resolution sufficient to quantify a neurochemical profile composed 14 metabolites. The same neurochemical profile was determined with only 3 minutes of scan time at 7.0 T Mekle et al., 2009; Tká c et al., 2009) and at 9.4 T (Deelchand et al., 2010) . This means that, at high field, the variety of neurochemicals detected in the human brain increasingly resemble those in rodents, that is, 20 metabolites. MRS is therefore a reliable method for diagnosing neurologic disorders and monitoring therapy outcomes, allowing early disease detection and preventive approaches. Furthermore, because the exact same tool can be applied noninvasively to rodents, high-field 1 H MRS in animal models with specific neuropathological phenotypes became a method of choice for translational research aiming at understanding biochemical mechanisms of disease development and progression. The aim of this study was to investigate the longitudinal modification of the neurochemical profile in vivo in the cortex, hippocampus, and striatum of C57BL/6 mice by 1 H MRS at 14.1 T. The analysis of these 3 brain areas aimed at depicting a diversity of brain functions and targets of neurologic disorders.
Methods

Animals
All experiments were conducted under approval of the local ethics committee in C57BL/6 mice that were born in the local animal facility. Mice were housed on a 12-hour light-dark cycle with room temperature at 22 C and humidity at 50%e60%. Regular chow and tap water were provided ad libitum. The neurochemical profiles of hippocampus, cortex, and striatum were determined longitudinally in 36 mice (19 males and 17 females) at the age of 3, 6, 12, 18, and 24 months. All scans were performed during the lightcycle under anesthesia of 1%e1.5% isoflurane in oxygen gas and the duration of each NMR scanning session was restricted to a maximum of 120 minutes (Kulak et al., 2010) .
MRS
Mice were fixed in a mouse holder with a bite bar and 2 ear inserts (RAPID Biomedical GmbH, Rimpar, Germany). Body temperature was maintained at 37 C by warm water circulation. All experiments were carried out in a horizontal 14.1 T/26 cm magnet (Magnex Scientific, Abingdon, UK), with a 12 cm inner-diameter gradient (400 mT/m in 200 ms, minimized eddy currents), interfaced with a DirectDrive console (Agilent Technologies, Palo Alto, CA, USA). Radio frequency transmission and reception was achieved with a home-built quadrature surface coil composed of 2 geometrically decoupled single-turn loops of 12 mm inner diameter resonating at 600 MHz. The mouse brain was positioned in the isocenter of the magnet and located with fast-spin-echo images with repetition time of 4 seconds, echo time of 52 ms, and echo train length of 8. Field homogeneity in the region of interest was achieved with FAST(EST)MAP (Gruetter, 1993; Gruetter and Tká c, 2000) . Volumes of interest were placed in the hippocampus H NMR spectra from the hippocampus (A), cortex (B) and striatum (C) of a 2-year-old female mouse acquired with SPECIAL at 14.1 T. Spectra were processed with Gaussian multiplication (gf ¼ 0.08, gfs ¼ 0.02), Fourier transformation and phase correction. Residual water signal removal or baseline correction was not applied. On the right of each spectrum, a representative fast-spin-echo image was used to show typical location of the volume of interest for spectroscopy. Metabolites in the spectra are assigned as follows: lactate (1), alanine (2), g-aminobutyrate or GABA (3), N-acetylaspartate (4), N-acetylaspartylglutamate (5), glutamate (6), glutamine (7), glutathione (8), aspartate (9), phosphocreatine (10), creatine (11), phosphorylcholine (12), glycerylphosphorylcholine (13), taurine (14), scyllo-inositol (15), myo-inositol (16), glycine (17), ascorbate (18), glucose (19), phosphorylethanolamine (20).
(1.3 Â 1.9 Â 1.8 mm 3 ), cortex (0.8 Â 4.2 Â 1.6 mm 3 ), or striatum (2.0 Â 1.8 Â 2.0 mm 3 ) of the C57BL/6 mice. NMR spectra were acquired using SPECIAL (Mlynárik et al., 2006) with echo time of 2.8 ms, repetition time of 4 seconds, and typically with 320e400 scans. Metabolite concentrations were determined using the linear combination analysis method LCModel (Stephen Provencher Inc, Oakville, Ontario, Canada), including a macromolecule (Mac) spectrum in the database (Mlynárik et al., 2006; . The unsuppressed water signal measured from the same volumes of interest was used as an internal reference for the absolute quantification of metabolites. The following 20 metabolites were included in the LCModel analysis: alanine (Ala), ascorbate (Asc), aspartate (Asp), creatine (Cre), g-aminobutyrate (GABA), glutamine (Gln), glutamate (Glu), glutathione (GSH), glycine (Gly), glycerophosphorylcholine (GPC), glucose (Glc), lactate (Lac), myo-inositol (Ins), N-acetylaspartate (NAA), N-acetylaspartylglutamate (NAAG), phosphorylethanolamine (PE), phosphorylcholine (PCho), phosphocreatine (PCre), scyllo-inositol (scyllo), and taurine (Tau). The CraméreRao lower bound (CRLB) was provided by the LCModel as a measure of the reliability of the apparent metabolite concentration quantification. In most measured spectra, the present analysis was not able to reliably discern phosphorylcholine from glycerophosphorylcholine. Therefore, their sum was quantified as total choline-containing compounds (GPC þ PCho or tCho). Because the relative content of creatine (Cre) and phosphocreatine (PCre) may depend on the energy status of the tissue, the total creatine concentration (Cre þ PCre or tCre) was reported as a constitutive metabolic pool of the tissue. The ratios of PCre to Cre, Gln to Glu, and Asp to Glu were also analyzed.
Water content
Tissue water content was used for absolute quantification of neurochemicals. Thus, in another set of mice, water content variations during aging were determined in the cortex, hippocampus, and striatum at the age of 6, 12, and 24 months by the difference in wet and dry tissue weights. After decapitation under isoflurane Fig. 2 . Age-dependent modification of concentration of compounds that compose the neurochemical profile in the cortex (triangles), striatum (circles), and hippocampus (squares) of C57BL/6 mice. Neurochemical modifications were measured from 1 H NMR spectra acquired in vivo longitudinally from the 3 regions of the mouse brain aged 3, 6, 12, 18, and 24-month-old. x, þ, and # represent significant differences at p < 0.01 compared with 3 months for the hippocampus, cortex, and striatum, respectively. Double symbols depict p < 0.001. anesthesia, brain tissue was collected, weighed, and let to dry at 65 C until dry weight did not vary. After desiccation, water content was calculated from the wet-dry weight difference. For younger animals, water content measurements were available from previous reports (Agrawal et al., 1968; Cohadon and Desbordes, 1986; Kulak et al., 2010; Larvaron et al., 2006) .
Statistical analysis
Results are presented as mean AE standard error of the mean. Data were analyzed in IBM SPSS 20 (IBM Corp, Armonk, NY, USA) with multivariate analysis of variance (MANOVA), performed with respect to metabolite in the neurochemical profile, brain region and mouse gender, having age as a repeated factor. Then, metabolite-specific age effects with confidence level above 90% (p < 0.1) were followed up with paired t tests, for which significance level was set at p < 0.01. Correlation between quantified metabolites was tested with the Pearson correlation analysis to all measured datasets, that is, including 3 brain regions, 5 ages, and both genders.
Results
Quantification of neurochemicals
Typical
1 H NMR spectra from the rat brain in vivo exhibited excellent metabolite line widths ( Fig. 1 ). In particular, for spectra acquired in the hippocampus, cortex, and striatum, respectively, average line width at half maximum was 16.1 AE 0.4 Hz, 19.7 AE 0.6 Hz, and 16.3 AE 0.5 Hz, as estimated by the LCModel. Water was consistently well suppressed and signal to noise was 21.0 AE 0.5, 18.4 AE 0.4, and 16.3 AE 0.3 in spectra from the hippocampus, cortex and striatum. This allowed determining a neurochemical profile of 19 metabolites that were quantified with CRLB generally below 25%. CRLB for glucose and phosphorylethanolamine were below 30% and for scyllo-inositol were lower than 40%. In this study, water content was quantified by desiccation for the hippocampus, cortex, and striatum and used to determine absolute metabolite concentrations. Water fraction did not differ within experimental accuracy between the 3 measured regions of the mouse brain, but was substantially reduced with aging. At the age of 6 and 12 months, water content was 79 AE 1% (n ¼ 4) and 79 AE 1% (n ¼ 6), respectively, and reduced to 75 AE 1% at the age of 24 months (n ¼ 9, p < 0.01 vs. 6 and 12 months). Average reported water content at the age of 1 month was 80 AE 1% (Agrawal et al., 1968; Cohadon and Desbordes, 1986; Kulak et al., 2010; Larvaron et al., 2006) . Water content at these ages and interpolated at the age of 3 and 18 months was used to estimate absolute concentration of metabolites in the brain.
Regional variation of metabolite concentrations
Regional specificity of spectral lines was directly evident from the relative height of NAA, creatine, and taurine peaks in 1 H NMR spectra acquired in vivo in the cortex, striatum, and hippocampus of adult mice (Fig. 1) . The concentration of metabolites in the neurochemical profile across the brain regions varied between the age of 3 and 24 months (Fig. 2) . Analysis of these results with MANOVA clearly indicated that the neurochemical profile is region specific (Supplementary Table 1 ). Although only glucose was not statistically different in the 3 brain regions (F ¼ 1.431, p > 0.05), the age evolution of metabolite concentrations was generally similar, except for taurine, NAAG, and glycine that displayed significant region-age or region-age-gender interactions (Supplementary Table 1 ).
Aging-dependent neurochemical modifications
The most prominent age-dependent neurochemical modifications were in the concentration of metabolites involved in neurotransmission, energy metabolism, or maintenance of cellular membranes (Fig. 2, Supplementary Tables 1 and 2 ). In particular, the main excitatory and inhibitory neurotransmitters, glutamate and GABA, were substantially reduced upon aging in the measured regions (p < 0.001). Compared with young adult mice, that is, at the age of 3 months, glutamate was reduced in the hippocampus, cortex, and striatum of 2-year-old mice by 13 AE 1%, 11 AE 2%, and 17 AE 2% (p < 0.001) and GABA was decreased by 10 AE 3%, 19 AE 6%, and 27 AE 3% (p < 0.001), respectively. Aspartate was also reduced (p < 0.05) in the cortex (À25 AE 5%, 24 vs. 3 months) and hippocampus (À19 AE 5%, 24 vs. 3 months) but not in striatum (þ44 AE 15%, 24 vs. 3 months).
This modification in levels of neuroactive-amino acids was accompanied by a reduction in the concentration of glucose (p < 0.01, 24 vs. 3 months: À19.6 AE 6.3%, À20.6 AE 8.4%, and À44.0 AE 5.9% in the hippocampus, cortex, and striatum, respectively), as well as in lactate (p < 0.001) and/or alanine (p < 0.001).
Compounds involved in lipid metabolism and plasma membrane turnover were modified in the 3 measured regions. Namely, while aging was associated with a reduction in the concentration of phosphorylethanolamine in the hippocampus, cortex, and striatum (p < 0.001; À34 AE 5%, À30 AE 7%, and À36 AE 6% for 24 vs. 3 months, respectively), choline-containing compounds increased over the 2 years (p < 0.01; 24 vs. 3 months: þ12 AE 2%, þ14 AE 3%, and þ2 AE 2% in the hippocampus, cortex, and striatum, respectively).
The content of myo-inositol was reduced after the age of 3 months and displayed a tendency to increase in brain regions of 2-year-old mice (p < 0.01), while the other isomer of inositol present in the brain in important amounts, scyllo-inositol, increased with age (p < 0.05). Total creatine, which is frequently taken as a reference compound in MRS studies, was found to decrease with age in the hippocampus, cortex, and striatum by À4 AE 1%, À5 AE 2%, and À7 AE 2%, respectively (24 vs. 3 months, p < 0.05). In adult mice, taurine concentration only varied with age in the striatum (À13 AE 4% for 24 vs. 3 months, p < 0.05). Glutathione showed an evolving pattern similar to that of taurine, being modified in the striatum Fig. 3 . Relevant metabolite ratios are modified upon aging in the mouse brain. Hippocampus, cortex, and striatum are represented by squares, triangles, and circles, respectively; x, þ, and # represent significant differences at p < 0.01 compared with mice aged 3 months for the hippocampus, cortex, and striatum, respectively. Double symbols depict p < 0.001.
(À17 AE 4% for 24 vs. 3 months, p < 0.01), but not in the other measured regions.
Important metabolite ratios were determined and also displayed regional specific and/or age-dependent modification: Gln to Glu, Asp to Glu, PCre to Cre (Fig. 3) . Most prominently, Gln to Glu increased with age in the hippocampus, cortex, and striatum by þ16 AE 4%, þ10 AE 3%, and þ32 AE 4%, respectively (24 vs. 3 months, p < 0.05).
Correlation between neurochemicals
Pearson correlation coefficients (r) were calculated to find probable linear dependences between measured metabolites and/ or metabolite ratios. As depicted in Fig. 4A , besides the obvious correlation of metabolites and their calculated concentration ratios, many compounds of the neurochemical profile were significantly correlated. The strongest correlation was found between the two putative neuronal markers NAA and glutamate (r ¼ 0.821, p < 0.01; plot in Fig. 4B ). Linear fit of glutamate to NAA concentrations across the brain region, age, and mouse gender, resulted in a significant slope of 1.0 AE 0.1 (F ¼ 170.9, p < 0.0001) and y-intercept of 0.8 AE 0.6 mmol/g (R 2 ¼ 0.859). While the putative glial marker myo-inositol and glutamine that is specifically produced in glial cells by glutamine synthetase did not generally correlate (r ¼ À0.034, p > 0.05), a linear relation between glutamine and myo-inositol was specifically detected in the cortex (R 2 ¼ 0.659; slope of 0.58 AE 0.15 with F ¼ 15.47, p < 0.01; y-intercept of 0.25 AE 0.65 mmol/g, Fig. 4C ). Among other significant correlations throughout all regions (Fig. 4A ), we found: taurine and choline-containing compounds (r ¼ 0.633, p < 0.01), myo-inositol and total creatine (r ¼ 0.519, p < 0.01), glutamate and aspartate (r ¼ 0.558, p < 0.01). Interestingly, less strong but significant correlations were found between lactate and physiologically important metabolite ratios (Fig. 4D) , namely Gln to Glu (r ¼ 0.311, p < 0.01), Asp to Glu (r ¼ À0.261, p < 0.01), and PCre to 
Gender differences
The evolution of the neurochemical profile with age was dependent on gender, most importantly in taurine, ascorbate, and total creatine content (p < 0.001, Fig. 5A ). A gender effect was also found for the evolution of glucose (p < 0.05), lactate and alanine (p < 0.01 for both), as well as for phosphorylethanolamine (p < 0.01) and aspartate (p < 0.05). Interestingly, because taurine is a substantially concentrated metabolite in the mouse brain, reaching concentrations that range between 7 and 15 mmol/g, the simple combination of taurine content with levels of NAA and myo-inositol, allowed to directly separate neurochemical profiles by both scanned brain region and mouse gender (Fig. 5B) .
Discussion
The present study reports, for the first time, longitudinal neurochemical modifications in the cortex, hippocampus, and striatum of the aging mouse, measured noninvasively by high-field 1 H MRS. The most prominent modifications were in metabolites involved in the processes of neurotransmission, energy production, and membrane lipid metabolism.
Neurotransmitters such as glutamate and GABA decreased during aging, suggesting reduction of synaptic function. In line with this, age-dependent reduction in the density of synaptic proteins were reported in the rodent brain, namely SNARE complex proteins, vesicle-mobilizing proteins, vesicular neurotransmitter transporters, postsynaptic proteins, and components of the synaptic vesicle cycle (Canas et al., 2009; VanGuilder et al., 2010) , which can contribute to the hippocampal function decline and thus to reduction of memory performance (Allard et al., 2012; Gage et al., 1984a; Kennard and Woodruff-Pak, 2011; Pistell et al., 2012) . Because glutamine is exclusively synthesized in glial cells mostly from synaptic-born glutamate, and then shuttled back to replenish glutamate neurotransmitter pools in neurons, Gln/Glu may reflect glutamate-glutamine cycle activity between neurons and glial cells. In line with this, the aging-associated reduction of synaptic connectivity was accompanied by Gln/Glu increase in the cortex, striatum, and hippocampus. For a long time, noninvasive detection of a peak corresponding mainly to resonances of both glutamate and glutamine in the cerebral tissue has been taken as a marker of function and degeneration in the preclinical and clinical studies. An independent noninvasive measure of both and also their ratio at high-magnetic field strength may provide a more specific marker to indicate neuronal function and dysfunction (as glutamate and glutamine are mostly located in neurons and glia, respectively). For example, impaired neurotransmission and excitotoxicity after an ischemic insult lead to transient glutamate decrease and glutamine accumulation (Berthet et al., 2011; Lei et al., 2009 ). In line with this idea, disturbed glutamatergic neurotransmission in schizophrenia leads to altered levels of glutamine, glutamate, and most notably of Gln/Glu, as observed in translational and clinical 1 H MRS studies (Bustillo et al., 2009; Hashimoto et al., 2005; Lutkenhoff et al., 2008; Shirayama et al., 2010; Tayoshi et al., 2009 ). In the healthy mouse brain, we observed a tendency (p ¼ 0.076) for loss of NAA in the hippocampus and striatum with aging but not in the cortex, where its concentration was the highest (Fig. 2) . NAA is mainly produced and stored in neurons and shuttled to oligodendrocytes for myelin production, and it has been used as a marker of neuronal function or density (reviewed in . Similarly, glutamate mainly resides in neurons, being readily converted to glutamine in glial cells McKenna, 2007 and references therein) . Accordingly, the results in Fig. 4 show good correlation between the levels of NAA and glutamate in the mouse brain in vivo.
In contrast, increased levels of myo-inositol have been taken as marker of astrogliosis and, in fact, in Alzheimer's disease, while NAA loss is frequently associated with neuronal degeneration, increased levels of myo-inositol are often related to other specific markers of astrocyte reactivity (discussed in . This is however debatable and some studies failed to find a correlation between pathology-associated astrogliosis and myo-inositol levels Kim et al., 2005; Kunz et al., 2011) . In addition, glutamine synthetase is specific to glial cells and we found a linear relation between myo-inositol and glutamine concentrations only in the cortex, suggesting that myo-inositol cannot be taken as a general marker of astrogliosis (Fig. 4C) .
The age-dependent modifications now observed in the mouse brain resemble those in humans. For example, an elegant study by Boumezbeur et al., (2010) found a reduction in NAA (À10%) and glutamate (À14%) and increase in myo-inositol (þ25%) concentrations in the brain of elderly humans, compared with young subjects, which could result in higher Gln/Glu (Fig. 3) . In addition, neuronal and glial mitochondrial metabolism and glutamate-glutamine cycle flux was lower in elderly subjects (Boumezbeur et al., 2010) .
Glucose transport and consumption vary between brain regions and they result in lower glucose content in the striatum, compared with the hippocampus and cortex (reviewed in Barros et al., 2007) . Although regional variation of glucose levels was not found because isoflurane anesthesia alters glucose homeostasis , lactate that results from glycolytic metabolism had distinct levels in the cortex, striatum, and hippocampus. Furthermore, lactate levels decreased with age, which is in accordance with reduced cerebral glucose utilization upon aging (Gage et al., 1984b; Tack et al., 1989) . This difference in lactate content may be indicative of the relative rates of cytosolic glycolysis and mitochondrial oxidative metabolism, further supported by putative differences in PCre/Cre, which is indicative of adenosine 5 0 -triphosphate (ATP) buffering by creatine kinase, and Asp/Glu, which may indicate integrity of the malate-aspartate shuttle in mitochondria. Aspartate and glutamate are essential for the transport of reducing equivalents from cytosol into mitochondria through the malateaspartate shuttle to be oxidized in the electron chain and produce ATP. Asp/Glu was not significantly altered by aging but demonstrates regional differences, that is, it was lower in the striatum compared with the other regions. This suggests differences in cytosolic production of reducing equivalents produced in glycolysis that are then transferred into the mitochondrial matrix through the malate- aspartate shuttle, a major step in neuroenergetics McKenna, 2007) . Therefore, measurement of these 2 amino acids may link excitatory neurotransmission to energy production and consumption Kunz et al., 2011) .
Lactate levels correlated with Gln/Glu, suggesting that glutamine accumulation in astrocytes, possibly because of increased glutamate-glutamine cycling, was associated with an increased rate of glycolysis relative to that of mitochondrial oxidative metabolism, in accordance to the increased glucose consumption rate with brain activity (discussed in Gruetter, 2012a, 2012b) . In line with this, increased brain activity leads to ammonia accumulation that requires detoxification through glutamine synthesis (discussed in Merle and Franconi, 2012) . A positive association of lactate concentration with Gln/Glu is in agreement with the proposed coupling of glial glycolysis and excitatory glutamatergic neurotransmission (Pellerin and Magistretti, 2012) . In addition, concentration of brain lactate was inversely associated to PCre/Cre and Asp/Glu, which is explained by higher rate of glycolysis when there is less storage of high energy phosphates by the buffer system operated by creatine kinase, that is, less abundance of ATP, and consequent increased rate of the aspartate aminotransferase that is essential for the malate-aspartate shuttle.
Compounds involved in membrane metabolism were modified with age. In particular, phosphorylethanolamine content was reduced while tCho increased. Because in the brain choline is below the NMR detection limit and mainly GPC and PCho contribute to this intense resonance, the measured cholinecontaining compounds are likely reflecting membrane lipid synthesis rather than the biosynthesis of the neurotransmitter acetylcholine (reviewed in . During early development, brain choline increases with age in the mouse cortex (Kulak et al., 2010 ). The present study shows that this increase of tCho with age continued through adulthood and aging and that this increase was not specific to the cortex. As reviewed in , total choline concentration in the human brain is positively correlated with age, which has been attributed to increased release of water-soluble choline-containing compounds from cell membranes, reflecting higher membrane turnover. Phosphorylethanolamine is a precursor for phosphatidylethanolamine, which is a major phospholipid in the brain, and its concentration decreases during cerebral development in both rodents and humans, paralleling the decrease of myelination and cellular proliferation . Like tCho, phosphorylethanolamine levels continued their developmental trend for decrease during adulthood and aging. The inverse trajectory in the evolution of tCho and phosphorylethanolamine levels in the aging brain may be related to modifications in cell membrane fluidity (Calderini et al., 1983) . In line with this, a 31 P MRS study showed that the glycerylated forms of such phospholipids increase with age in the human brain (Blüml et al., 1999) . Frequently, total creatine is used as a reference for the remaining metabolite concentrations. However, its concentration (signal) was found to change in certain pathologic conditions , during postnatal development (Kulak et al., 2010) and between gray and white matter (Mukherjee et al., 2000) . Reduction of total creatine concentration with age was observed in the cortex, hippocampus, and striatum during aging (Fig. 2) , suggesting that care should be taken when using creatine as a normalization factor.
Our previous study on neurochemical modifications during early development in the mouse cortex demonstrated a marked reduction in taurine levels from the age of 10 days to 3 months (Kulak et al., 2010) . Taurine content was not modified with aging in the hippocampus or cortex in adult mice. In contrast, it continuously decreased during aging in the striatum, where it is most concentrated. Among other functions, taurine is also a neuromodulator and interacts with inhibitory GABA A , GABA B , or glycine receptors thus, displaying capability of modulating synaptic plasticity (reviewed in Albrecht and Schousboe, 2005) . This inhibitory role of taurine is especially important during the period of cortical synaptogenesis, when brain taurine levels are found to be the highest (Kulak et al., 2010; Tká c et al., 2003) . However, as a small fraction of taurine is involved in neuromodulation (particularly in the case of rodents), the main role of taurine may be rather related to osmoregulation, balancing modifications in glutamate, glutamine, NAA, and other major neurochemicals during development (Kulak et al., 2010) .
This study was performed in both male and female mice and the neurochemical profile was similar in both genders. Nevertheless, some neurochemical differences between genders were identified by MANOVA. In particular, taurine concentration that was consistently lower in the cortex and hippocampus of female mice, relative to age-matched males. In the striatum, this gender-associated difference in taurine levels was only present in aged mice. Thus, taurine concentration seems to be related to estrogen activity in the brain. Indeed, estrogen receptors regulate taurine uptake via the Na þ -dependent taurine transporter (TauT) in MCF-7 human breast cancer cells (Han et al., 2006; Shennan and Thomson, 2007) . Both estrogen receptors ERa and ERb are present in the mouse cortex, hippocampus, and striatum, although striatal levels of either messenger RNA or protein are much lower (Küppers and Beyer, 1999; Mitra et al., 2003; Shughrue and Merchenthaler, 2000) . Estrogen receptors modulate brain function and, like taurine, afford neuroprotection in the cortex and hippocampus (Shughrue and Merchenthaler, 2000) . Although the striatum is not protected by estrogen after ischemic injury (Shughrue and Merchenthaler, 2000) , estrogen receptors afford neuroprotection of striatal dopaminergic neurons in animal models of Parkinson's disease (Al Sweidi et al., 2012; Campos et al., 2012) , possibly by regulating dopamine transport (Di Liberto et al., 2012) or microgliosis (Liu et al., 2005) . It should be noted that during early development of the mouse cortex from P10 to adult age (Kulak et al., 2010) , most metabolite concentrations increased upon tissue differentiation, particularly glutamate, glutamine, aspartate, NAA, myo-inositol, creatine, and choline containing compounds. In the present study, while cortical glutamine and NAA levels were relatively stable (at a 3 and 8.5 mmol/g, respectively), tCho continued increasing, but glutamate, aspartate, and creatine concentrations decreased during adult age. Because the juvenile increase in brain metabolite concentrations appeared asymptotic toward adulthood (Kulak et al., 2010) , different mechanisms must drive metabolic alterations upon aging. The underlying mechanisms for these alterations remain to be explored.
In conclusion, the neurochemical profile varies upon healthy aging in the mouse brain and suggests that aging is associated to modifications of energy metabolism, synaptic transmission, and cell membrane turnover. Furthermore, while NAA and glutamate may be relevant markers for neuronal density or function, myoinositol does not appear to be a general marker for the glial compartment. This study provided the basal neurochemical profiles of the cortex, hippocampus, and striatum of healthy aging male and female mice. Because the neurochemical profile is specific for a given cerebral status and can also be measured in the human brain, it serves as a noninvasive biomarker for the detection of neurologic disorders and for therapy monitoring.
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